Washington, D.C. 20549


                                    FORM 6-K

                            Report of Foreign Issuer
                      Pursuant to Rule 13a-16 or 15d-16 of
                       the Securities Exchange Act of 1934

                         For the month of February, 2002


                            Bayer Aktiengesellschaft
             (Exact name of registrant as specified in its charter)

                              Bayerwerk, Gebaude W1
                               D-51368 Leverkusen
                    (Address of principal executive offices)


             Indicate by check mark whether the registrant files or
                 will file annual reports under cover Form 20-F
                                  or Form 40-F.

                           Form 20-F /X/   Form 40-F

           Indicate by check mark whether the registrant by furnishing
               information contained in this Form is also thereby
                          furnishing information to the
           Commission pursuant to Rule 12g3-2(b) under the Securities
                             Exchange Act of 1934.

                               Yes / /   No /X/

       If "Yes" is marked, indicate below the file number assigned to the
              registrant in connection with Rule 12g3-2(b): 82- N/A

                                  EXHIBIT INDEX

1.     One English-language version of a press release dated February 5, 2002,
announcing the receipt by Bayer of an offer from Teva Pharmaceutical Industries
Ltd. to purchase Bayer's French generic pharmaceuticals business.